Health Products

Prolia (denosumab) (2013-09-24)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDosage formDIN, NPN, DIN-HIMStrength
Lot # 1035671*
Recalling Firm
Amgen Canada Inc.
100 - 6775 Financial Drive
Mississauga
L5N 0A4
Ontario
CANADA
Marketing Authorization Holder
Amgen Canada Inc.
100 - 6775 Financial Drive
Mississauga
L5N 0A4
Ontario
CANADA
Prolia (denosumab) Solution for injectionDIN 0234354160 mg/mL (single-use prefilled syringe)

Introduction

Recalled Products

Prolia (denosumab) 

Reason

One lot of Prolia, lot 1035671 (packaged from Prolia batch 0010136386) is subject to a recall, after identifying the presence of particulate (cellulose) matter in a small number of pre-filled syringes.

Depth of distribution

Wholesalers in all provinces in Canada.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime